Selected examples of bilateral COVID-19 vaccine purchasing agreements, as of November 12, 2020 (source: https://launchandscalefaster.org/COVID-19)
| Purchaser (country) | Vaccine manufacturer | Number of doses committed by manufacturer to purchaser, millions | Total number of doses committed to purchaser, millions |
| USA | Oxford University | 300 | 810 |
| Janssen (J&J) | 100 | ||
| Moderna | 100 | ||
| Novavax | 110 | ||
| Pfizer | 100 | ||
| Sanofi-GSK | 100 | ||
| Canada | Novavax | 76 | 358 |
| Medicago | 76 | ||
| Sanofi-GSK | 72 | ||
| Moderna | 56 | ||
| Janssen (J&J) | 38 | ||
| Oxford University | 20 | ||
| Pfizer | 20 | ||
| UK | Oxford University | 100 | 340 |
| Novavax | 60 | ||
| Sanofi-GSK | 60 | ||
| Valneva | 60 | ||
| Janssen (J&J) | 30 | ||
| Pfizer | 30 | ||
| Japan | AstraZeneca | 120 | 240 |
| Pfizer | 120 |